Caxton Associates (New York)’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-45,000
Closed -$11.6M 467
2023
Q4
$11.6M Buy
+45,000
New +$11.1M 0.6% 43
2022
Q1
Sell
-2,332
Closed -$559K 524
2021
Q4
$559K Buy
+2,332
New +$600K 0.06% 252
2020
Q4
Sell
-1,110
Closed -$315K 155
2020
Q3
$315K Sell
1,110
-222
-17% -$61.9K 0.03% 189
2020
Q2
$356K Sell
1,332
-3,943
-75% -$1.19M 0.03% 205
2020
Q1
$1.67M Buy
+5,275
New +$1.6M 0.31% 25
2018
Q4
Sell
-5,867
Closed -$2.07M 289
2018
Q3
$2.07M Buy
+5,867
New +$2.02M 0.14% 121
2018
Q2
Sell
-2,671
Closed -$731K 376
2018
Q1
$731K Sell
2,671
-195
-7% -$60.5K 0.04% 222
2017
Q4
$913K Buy
+2,866
New +$919K 0.04% 221
2017
Q3
Sell
-1,500
Closed -$407K 494
2017
Q2
$407K Buy
1,500
+300
+25% +$79.3K 0.02% 403
2017
Q1
$328K Buy
+1,200
New +$339K ﹤0.01% 334
2014
Q2
Sell
-10,000
Closed -$3.06M 181
2014
Q1
$3.06M Buy
+10,000
New +$3.17M 0.19% 94

Other funds holding BIIB